Skip to content

METABAR-MS study

Impact of metabolic and bariatric surgery on the clinical course of multiple sclerosis - METABAR-MS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58058
Enrollment
40
Registered
2025-03-14
Start date
2025-06-18
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, MS, morbid obesity MS, severe overweight

Interventions

The intervention consists of undergoing metabolic and bariatric surgery (MBS) in patients diagnosed with MS.&nbsp

Sponsors

Albert Schweitzer Ziekenhuis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: MS according to MS diagnostic criteriaHas undergone primary MBS  between 1-1-2011 and 1-12-2023Age = 18 yearsA stable or increasing eEDSS over the last two preoperative yearsMS-parameters available from = 2 years before MBS until = 1 year after MBSAvailable information about BMI from 2 year before until 1 year after MBS, type of MBS and MBS related complications

Exclusion criteria

Exclusion criteria: Diagnosed with MS after MBSNo information about age, gender and preoperative BMI (for matching)None of the following MS-related outcomes measures available: eEDSS, radiological activity, annual relapse rate, T25FW, type of immune modulatorion therapy 

Design outcomes

Primary

MeasureTime frame
The estimated Expanded Disability Status Scale (eEDSS) is a validated outcome measure for assessing disability in patients with MS.

Secondary

MeasureTime frame
Radiological disease activity (occurrence of new and/or enhanced lesions on MRI), annual relapse rate, Timed-25-Foot-Walk (T25FW), switch of Disease-Modifying Therapy (DMT), body weight,  body mass index, postoperative morbidities after MBS, obesity-related comorbidities

Countries

Netherlands

Contacts

Public ContactM Ponsioen

Albert Schweitzer Ziekenhuis

metabar-ms@asz.nl(078) 654 51 50

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)